SCHEMBL3660080

SCHEMBL3660080

O=C(O)c1cc2ccccc2nn1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAM O43451 2/20 0.57
ALDH1A1 P00352 5/20 0.50
ALOX15 P16050 3/20 0.50
HPGD P15428 3/20 0.50
HSD17B10 Q99714 2/20 0.50
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
KDM4E B2RXH2 5/20 0.46
TSHR P16473 1/20 0.46
ACMSD Q8TDX5 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
GLA P06280 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
ACHE P22303 1/20 0.44
LMNA P02545 2/20 0.43
CNR2 P34972 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30212114 1.00 MGAM (0.57) MGAMALDH1A1ALOX15HPGDHSD17B10
Water SCHEMBL28321872 0.98 MGAM (0.55) MGAMALDH1A1ALOX15HPGDHSD17B10
Ammonia Solution, Strong SCHEMBL9496314 0.98 MGAM (0.55) MGAMALDH1A1ALOX15HPGDHSD17B10
Hydrochloric Acid SCHEMBL10514366 0.98 MGAM (0.55) MGAMALDH1A1ALOX15HPGDHSD17B10
SCHEMBL5361607 0.86 KDM4E (0.44) MGAMALDH1A1ALOX15HPGDHSD17B10
SCHEMBL30824210 0.84 KDM4E (0.43) MGAMALDH1A1ALOX15HPGDHSD17B10
SCHEMBL10514362 0.84 KDM4E (0.43) MGAMALDH1A1ALOX15HPGDHSD17B10
SCHEMBL965159 0.84 IKBKB (0.51) MGAMALDH1A1HPGDMAPTKDM4E
SCHEMBL2007758 0.84 KDM4E (0.43) MGAMALDH1A1ALOX15HPGDHSD17B10
Hydrochloric Acid SCHEMBL27798246 0.82 IKBKB (0.50) MGAMALDH1A1HPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111278817-B Polycyclic compounds as farnesol X receptor modulators 百时美施贵宝公司 2023-05-16 CN claimed
CN-1826140-A Combination therapy for the treatment of bacterial infections UPJOHN CO (US) 2006-08-30 CN claimed
EP-0725651-B1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1999-08-11 EP claimed
US-5830867-A Hemoregulatory peptides for stimulating the myelopoietic system SMITHKLINE BEECHAM CORPORATION (US) 1998-11-03 US claimed
US-5652219-A Hemoregulatory peptides SMITHKLINE BEECHAM CORPORATION (US) 1997-07-29 US claimed
EP-0701446-A4 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1997-04-23 EP claimed
EP-0621788-A4 HEMOREGULATORY PEPTIDES. SMITHKLINE BEECHAM CORP (US) 1997-03-05 EP claimed
EP-0725651-A4 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORP (US) 1997-03-05 EP claimed
EP-0725651-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1996-08-14 EP claimed
EP-0701446-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1996-03-20 EP claimed
WO-1995011693-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1995-05-04 WO claimed
WO-1994027627-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-12-08 WO claimed
EP-0621788-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1994-11-02 EP claimed
WO-1993013789-A1 HEMOREGULATORY PEPTIDES SMITHKLINE BEECHAM CORPORATION (US) 1993-07-22 WO claimed
US-4968507-A SUSTAINED RELEASE OF DRUG MERCK & CO., INC. (US) 1990-11-06 US claimed
US-4851228-A Multiparticulate controlled porosity osmotic MERCK & CO., INC. (US) 1989-07-25 US claimed
US-4705789-A Solutions of lactic acid salts of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids BAYER AKTIENGESELLSCHAFT (DE) 1987-11-10 US claimed
JP-5310732-A None JP disclosed
US-4027023-A FOR TREATING ANTIGEN-ANTIBODY REACTION SYNDROMES IMPERIAL CHEMICAL INDUSTRIES LIMITED (EN) 1977-05-31 US disclosed
US-4027023-A FOR TREATING ANTIGEN-ANTIBODY REACTION SYNDROMES IMPERIAL CHEMICAL INDUSTRIES LIMITED (EN) 1977-05-31 US disclosed